An observational study in General Surgery and Disease Outbreaks, sponsored by Azienda Socio Sanitaria Territoriale di Lodi. Completed at 1 site in Italy. Per ClinicalTrials.gov, last updated 2020-06-16.
Sponsored by Azienda Socio Sanitaria Territoriale di Lodi · Observational
The investigators retrospectively evaluated all the patients operated in a high-risk community hospital from the first Italian case of Covid-19 (February 21st) to the April 10th (in order to have at least a 30-days follow-up). The investigators selected those patients who had a preoperative or post-operative positive Real Time - Polymerase Chain Reaction (RT-PCR) for SARS-CoV-2 and the clinical outcome of the participants was evaluated in term of need of Intensive Care Unit (ICU) post-operative recovery, medical and surgical complications, length of hospital stay and death.
7,990 studies on the registry are indexed under COVID-19; 466 are open to participants now.
This study's enrollment of 14 is below the median of 268 across 3,208 observational studies indexed under COVID-19.
Browse COVID-19 studies →Azienda Socio Sanitaria Territoriale di Lodi is the lead sponsor of 5 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
General population referring to a community hospital during the SARS-CoV-2 outbreak in the Northern Italy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Procedure: Surgical procedures performed under general anesthesia
Surgical procedures performed under general anesthesia in patients with perioperative SARS-CoV-2 infection
Mortality
Time frame: 30 days
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda Socio Sanitaria Territoriale di Lodi